Details 
The Stanford Biodesign Innovation Program, in cooperation with Windhover Information, Wilson Sonsini Goodrich & Rosati and PricewaterhouseCoopers present a unique opportunity to hear our final guest innovator for the 2004 series Dr. Simon Stertzer, interviewed by David Cassak, Managing Partner, Windhover Information. Simon Stertzer is an internationally recognized pioneer in catheter-based coronary interventions. He was the first practitioner of PTCA in the United States and has played a pivotal role in the development of balloon and guiding catheter technology. More recently, he has been involved with innovative designs for stents and intracoronary drug delivery. Dr. Stertzer’s research includes: intracoronary drug delivery via polymer stents, local delivery of plasma, DNA and other molecules into myocardial cells, advanced atherectomy and stent techniques and micro-encapsulated drug delivery of pharmaceuticals. Dr. Stertzer received his M.D. from New York University.
|
|
|